Kelly George supports clients in navigating the regulatory strategy and FDA policy environment for products in the space of drugs, biologics, and medical devices.
Trained as a peptide chemist, she provides in-depth technical knowledge to guide clients by translating technical information into clear strategic policy responses.
Prior to joining Avalere, Kelly focused on pipeline technologies in pre-FDA approval phases of development at the Innovation Institute. Prior to that, she worked as a scientific consultant with Fourth River Solutions where she focused on business strategy development and in-depth market analysis on medical devices.
Kelly has a PhD in peptide chemistry from the University of Pittsburgh and a BS in biology from James Madison University.
For even deeper coverage, download the 2021 Healthcare Industry Outlook document below.